In non-small cell lung cancer (NSCLC), EGFR palmitoylation regulates the interaction between PI3K regulatory subunit PIK3R1 (p85) and EGFR, enhancing recruitment of PI3K heterodimers to the plasma membrane and amplifying downstream AKT activation. Here, PIK3R1 is linked to non-small cell lung carcinoma.